Overall, we concluded that ENO1 synergistically regulated the PI3K/AKT and AMPK/mTOR pathways through direct stimulation of glycolytic products and influenced the ATP pool and lactate homeostasis, ultimately promoting the stemness and tumor growth of GCs (Fig. 6). The gene discussed is ENO1; the disease is neoplasm.